If you had a lower thoracic injury (i.e. T11, T12), you may have damaged the lumbar enlargement and the CPG. If you have a L1 or lower injury, your CPG may be intact.
Nordic Life Science Pipeline Inc. names new acting Chief Medical Officer
They are planning to conduct a Spinalon phase II-B trial (expected for 2015) in US, Europe, Canada.
I believe the first trial was a 2 arm (Phase 1 and 2-A). The upcoming one would be a 2-B.
The current trial on 51 people had this organization on it for the Phase 1 & 2A.
The proposed study is a combination of 1 and 2-arm designs. First, a 2-arm design will be used, the first arm being composed of 3 subjects receiving the lowest dose of the study drug, and the second arm being composed of 1 subject receiving a placebo. This 2-arm design will be repeated consecutively (not simultaneously) with increasing doses of SPINALON, as long as the dose is well tolerated. Six (6) groups are expected to be tested with this 2-arm design.This will be followed by a 2-arm composed of 1 group with 1 subject receiving placebo and 1 larger group (10 subjects) who will receive SPINALON at MTD as identified in the previous 2-arm groups.
Last edited by GRAMMY; 05-10-2014 at 12:56 AM.
"This worldwide ground-breaking discovery enables preparation of the next step – that is even larger-scale studies (1000 patients) to seek approval for sales within 5 years in Canada, Europe and United States" Holy hell, still 5 yrs away. I will be dead in another three or four intervals of 5 yr
Another 2-3 five year intervals and I'll be dead also.